These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7048878)

  • 1. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
    Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
    Ruddy MC; Bialy GB; Kostis JB
    Angiology; 1989 Jan; 40(1):45-50. PubMed ID: 2562912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and renin during treatment with pindolol.
    Fyhrquist F; Kurppa K; Huuskonen M; Koistinen A
    Acta Med Scand; 1977; 202(1-2):55-60. PubMed ID: 899884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.
    Stumpe KO; Kolloch R; Gramann W; Vetter H; Ressel C; Higuchi M; Krück F
    Klin Wochenschr; 1976 Aug; 54(16):775-82. PubMed ID: 957599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
    Winer N; Carter CH; Eddy H
    Am Heart J; 1982 Aug; 104(2 Pt 2):425-31. PubMed ID: 7048879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
    Geyskes GG; Boer P; Vos J; Leenen FH; Mees EJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):248-56. PubMed ID: 1093756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
    Morgan TO; Roberts R; Carney SL; Louis WJ; Doyle AE
    Br J Clin Pharmacol; 1975 Apr; 2(2):159-64. PubMed ID: 791319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
    Teeuw AH; Leenen FH; Geyskes GG; Boer P
    Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary function in hypertensive patients treated with pindolol: a report of two studies.
    Hamilton BP; Hamilton J; Kirkendall WM
    Am Heart J; 1982 Aug; 104(2 Pt 2):432-7. PubMed ID: 7048880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs.
    Fanchamps A
    Am Heart J; 1982 Aug; 104(2 Pt 2):388-406. PubMed ID: 6125096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pindolol and propranolol on plasma renin and aldosterone in patients with renal allograft.
    Wehling M; Kuhlmann U; Záruba K; Largiadèr F; Keusch G; Studer A; Vetter W
    Clin Nephrol; 1983 Nov; 20(5):231-4. PubMed ID: 6360452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pressure and renin activity in essential hypertension under pindolol].
    Nussberger J; Vetter W; Furrer J; Beckerhoff R; Würsten D; Schmied U; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Jun; 106(24):831-4. PubMed ID: 996500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension.
    Kolloch R; Stumpe KO; Vetter H; Gramann W; Krück F
    Clin Sci Mol Med Suppl; 1976 Dec; 3():537s-540s. PubMed ID: 799564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
    Morgan T; Carney S; Roberts R
    Clin Sci Mol Med Suppl; 1975 Jun; 2():81s-83s. PubMed ID: 802647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.
    Stokes GS; Graham RM; Weber MA
    Drugs; 1976; 11 SUPPL 1():150-6. PubMed ID: 6247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
    Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol and systolic time intervals in patients with hypertension.
    Hammond JJ; Kirkendall WM; Jacks-Nagle VL; Plotnick GD; Fisher ML; Hamilton JH; Robinson M; Carliner NH; Janoski AH; Hamilton BP
    Am Heart J; 1982 Aug; 104(2 Pt 2):456-64. PubMed ID: 7102532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.